Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
2.
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
Oncologist
; 28(5): 453-459, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724001
3.
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
Cancer
; 128(19): 3516-3522, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942596
4.
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications.
Oncologist
; 27(7): 595-599, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589095
5.
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Cancer
; 127(6): 894-904, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231866
6.
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.
Future Oncol
; 17(22): 2923-2939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855868
7.
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Lancet Oncol
; 20(12): 1719-1729, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31704134
8.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Lancet Oncol
; 18(11): 1493-1501, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988646
9.
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Cancer
; 123(1): 90-97, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696380
10.
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
Cancer
; 122(6): 868-74, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26710211
11.
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
BMC Cancer
; 16: 663, 2016 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544129
12.
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.
Cancer
; 120(16): 2448-56, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797726
13.
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 14(4): 371-82, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23477833
14.
A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
Clin Cancer Res
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446990
15.
Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial results.
Curr Opin Oncol
; 24(4): 419-24, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22510939
16.
Bayesian decision theoretic two-stage design in phase II clinical trials with survival endpoint.
Stat Med
; 31(17): 1804-20, 2012 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22359354
17.
Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumors.
Curr Treat Options Oncol
; 13(3): 285-98, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22610342
18.
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Clin Cancer Res
; 28(2): 271-278, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716198
19.
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
J Clin Oncol
; 40(22): 2479-2490, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394800
20.
Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
J Surg Oncol
; 104(8): 888-95, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22069173